| INTERNATIONAL | WP4 | |||
| Organization | ZIKAlliance | |||
| Name of cohort | ZIKAlliance SARS-CoV-2 substudy | |||
| Referring partner | UMCG | |||
| Cohort Information | Country(-ies), cities, regions or centers involved | UMCG, Groningen (Netherlands); UKHD, Heidelberg (Germany); Valencia (Venezuela); Lima (Perú); Bucaramanga (Colombia); Rio de Janeiro (Brazil) | ||
| Time of data collection | 08/2022 | Ongoing | ||
| Enrolment | Inactive | |||
| Study setting | Multi-centers | |||
| Population | Age | Children,Adults | ||
| Type | Retrospective | |||
| Total number of patients | 3111 | |||
| Type of frailty (WP4) | Pediatric,Pregnant | |||
| Data collection | Clinical data | True | ||
| Serological data | True | |||
| Genetic data | True | |||
| Sample collection | True | |||
| Sample collected | Whole blood | Yes | ||
| PBMC | No | |||
| Dry-spot blood | No | |||
| Plasma | No | |||
| Serum | No | |||
| Stool | Yes | |||
| NP swabs | Yes | |||
| Other | None | |||
| Description | The initial purpose of this cohort was the evaluation of risks of congenital malformations and other adverse pregnancy outcomes after Zika virus infection in pregnant women and their children. Future: we have integrated the investigation of SARS-CoV-2 infection and SARS-CoV-2 disease into the on-going Zika PW cohort study. | |||